Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
FDA recall notice · announced March 1, 2017 · Moore's Compounding Pharmacy
Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.
The product
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
Reason for recall
Superpotent Drug and Subpotent Drug; potency failures obtained
Notes
Distribution: TX
Lot/code information: 2016-08-22:37@28, exp 2/18/2017
Quantity: 90 capsules
Status: Terminated
Products in this recall event:
- Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX (D-0488-2017)
Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.